“cancer-drugs” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug 09/15/20 San Francisco
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout 09/14/20 San Francisco
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures 09/05/20 Boston
Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs 07/21/20 New York
Two Days, Six IPOs, and $1B Raised for Biotech Research & More 07/17/20 National
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
Gilead Grabs Option to Acquire Pionyr & Its Clinic-Bound Immunotherapies 06/23/20 San Francisco
GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance 06/16/20 San Francisco
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
ADC’s $233M IPO Brings It to NYSE With Cancer Drug Launch on Horizon 05/15/20 New York
Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug 05/08/20 Indiana
Novartis Drug Wins FDA Approval for Lung Cancers With Specific Mutation 05/06/20 National
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Immunomedics Triple Negative Breast Cancer Drug Wins Early FDA Nod 04/22/20 New York
FDA Approves Incyte Drug, First Ever for Rare Bile Duct Cancer 04/20/20 National
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer 04/15/20 Boston
Tango Adds $60M in CRISPR Hunt for Synthetically Lethal Cancer Drugs 04/09/20 Boston
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
ORIC Pharma Plans IPO to Test Therapies for Drug-Resistant Cancers 03/02/20 San Francisco
Page 1 of 3 next page »